Ipsen drug approved by FDA for early pancreatic cancer
BioPharma
Source: biopharmadive.com
Gi Oncology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gi Oncology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gi Oncology Program Today - Breaking & Trending Today
Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced...
Source: prnewswire.com
Camrelizumab With Rivoceranib Elicits PFS and OS Benefit Over Sorafenib in Unresectable HCC
Amit Mahipal, MD, discusses clinical outcomes with camrelizumab plus rivoceranib as first-line treatment in unresectable HCC, based on data from the randomized, open-label, international phase 3 CARES-310 trial.
Source: onclive.com
Test Predicts Which CRC Patients Benefit from Adjuvant Chemo
Testing for molecular residual disease was able to identify patients with early-stage colorectal cancer who are most likely to benefit from adjuvant chemotherapy.
Source: medscape.com
Dr Neil Sharma Offers State-of-the-art Care for Pancreatic Cancer
Every year, over 60,000 people develop new cases of pancreatic cancer, with nearly 48,000 dying every year from this disease. Dr. Neil Sharma MD of Parkview
Source: einnews.com